Therapy of primary cutaneous melanoma

Medical Clinics of North America

Volumn 70, Issue 1, 1986, Pages 71-87

  White, M J ^a   Polk, H C ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DACARBAZINE; DACTINOMYCIN; MELPHALAN;

BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; DIAGNOSIS; HUMAN; IMMUNOTHERAPY; INTRAARTERIAL DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM; MELANOMA; METASTASIS; PRIORITY JOURNAL; RADIOTHERAPY; REGIONAL PERFUSION; REVIEW; SKIN; SURGERY; THERAPY;

EID: 0022615567     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(16)30969-5     Document Type: Article

References (79)

1. D.R. Aitken K. Clausen J.P. Klein A.G. James The extent of primary melanoma excision Ann. Surg. 798 1983 634 641
2. E.M. Alrich J.L. Manwaring J.S. Horsley Ill: Isolation perfusion. An adjunct tosurgical excision in the primary treatment of melanoma of the extremities Am. J. Surg. 121 1971 583 585
3. I.M. Ariel Tridimensional resection of primary malignant melanoma Surg. Gynecol. Obstet 139 1974 601 603
4. C.M. Balch T.M. Murad S-J. Soong Tumor-thickness as a guide to surgical management of clinical stage I melanoma patients Cancer 43 1979 883 888
5. C.M. Balch S-J. Soong T.M. Murad A multifactorial analysis of melanoma.II Prognostic factors in patients with stage I (localized) melanoma Surgery 86 1979 343 351
6. C.M. Balch S-J. Soong T.M. Murad A multifactorial analysis of melanoma.III Prognostic factors in melanoma patients with lymph node metastases (stage II) Ann. Surg. 193 1981 377 388
7. C.M. Balch J.A. Wilkerson T.M. Murad The prognostic significance ofulceration of cutaneous melanoma Cancer 45 1980 3012 3017
8. O.H. Beahrs M.H. Myers Manual for Staging of Cancer 2nd ed. 1983 J. B. Lippincott Co., Philadelphia
9. K.I. Bland T.W. Klamer H.C. Polk Jr C.O. Knutson Isolated regionallymph node dissection. Morbidity, mortality and economic considerations Ann. Surg. 193 1981 372 376
10. A. Breslow Thickness, cross-sectional areas and depth of invasion in the prognosis ofcutaneous melanoma Ann. Surg. 172 1970 902 908
11. A. Breslow Tumor thickness, level of invasion and node dissection in stage I cutaneousmelanoma Ann. Surg. 182 1975 572 575
12. A. Breslow S.D. Macht Optimal site of resection margin for thin cutaneous melanoma Surg. Gynecol. Obstet. 145 1977 691 692
13. A.S. Bulman C.W. Jamieson Isolated limb perfusion with melphalan in thetreatment of malignant melanoma Br. J. Surg. 67 1980 660 662
14. B. Cady M.A. Legg A.B. Redfern Contemporary treatment of malignant melanoma Am. J. Surg. 129 1975 472 482
15. R. Cavaliere E.L. Ciocatto B.L. Gionavella Selective heat sensitivity ofcancer cells. Biochemical and clinical studies Cancer 20 1967 1351 1381
16. W.H. Clark Jr L. From E.A. Bernardino M.C. Mihm The histogenesis andbiologic behavior of primary human malignant melanomas of the skin Cancer Res. 29 1969 705 726
17. M.H. Cohen A.S. Ketcham E.L. Felix Prognostic factors in patientsundergoing lymphadenectomy for malignant melanoma Ann. Surg. 186 1977 635 642
18. K.R. Cox Survival after regional perfusion for limb melanoma Aust. N. Z. J. Surg. 45 1975 32 36
19. E.T. Creagan R.E. Cupps J.C. Ivins Adjuvant radiation therapy for regionalnodal metastases from malignant melanoma. A randomized, prospective study Cancer 42 1978 2206 2210
20. O. Creech Jr E.T. Krementz R.F. Ryan Chemotherapy of cancer: Regionalperfusion utilizing an extracorporeal circuit Ann. Surg. 148 1958 616 632
21. F. Dancuart A.R. Hardwood P.J. Fitzpatrick The radiotherapy of lentigomaligna and lentigo maligna melanoma of the head and neck Cancer 45 1980 2279 2283
22. T.K. Das Gupta Results of treatment of 269 patients with primary cutaneous melanoma:A five-year prospective study Ann. Surg. 186 1977 201 209
23. N.C. Davis Cutaneous melanoma: The Queensland experience Curr. Probl. Surg. May, 1976 1 63
24. E. Epstein K. Bragg G. Linden Biopsy and prognosis of malignant melanoma JAMA 208 1969 1369 1371
25. C.J. Fontaine C.W. Jamieson Perfusion in limb melanoma: Indications andresults Proc. R. Soc. Med. 67 1974 99 100
26. J.G. Fortner J. Woodruff D. Schottenfeld B. Maclean Biostatistical basis ofelective node dissection for malignant melanoma Ann. Surg. 186 1977 101 103
27. F. Ghussen K. Nagel W. Groth A prospective randomized study of regionalextremity perfusion in patients with malignant melanoma Ann. Surg. 200 1984 764 768
28. L.I. Goldman The treatment of malignant melanoma of the skin Surg. Gynecol.Obstet 146 1978 779 782
29. H.S. Goldsmith J.P. Shah D-H. Kim Prognostic significance of lymph nodedissection in the treatment of malignant melanoma Cancer 26 1970 606 609
30. W.S. Handley The pathology of melanotic growths in relation to their operative treatment Lancet 1 1907 927 933
31. M.N. Harris S.L. Gumport H. Maiwondi Axillary lymph node dissection formelanoma Surg. Gynecol. Obstet. 135 1972 936 940
32. M.N. Harris S.L. Gumport I.R. Berman R.W. Bernard Ilioinguinal lymphnode dissection for melanoma Surg. Gynecol. Obstet. 136 1973 33 39
33. E.C. Holmes H.S. Moseley D.L. Morton A rational approach to the surgicalmanagement of melanoma Ann. Surg. 186 1977 481 490
34. K.A. Janoff D. Moseson J. Nohlgren The treatment of stage I melanoma ofthe extremities with regional hyperthermic isolation perfusion Ann. Surg. 196 1982 316 323
35. D.P. Kapelanski G.E. Block M. Kaufman Characteristics of the primary lesionof malignant melanoma as a guide to prognosis and therapy Ann. Surg. 189 1979 225 235
36. C.P. Karakousis M.K. Seddig R. Moore Prognostic value of lymph node dissection in malignant melanoma Arch. Surg. 115 1980 719 722
37. J.W. Kelly R.W. Sagebiel W. Calderon The frequency of local recurrenceand microsatellites as a guide to reexcision margins for cutaneous malignant melanoma Ann. Surg. 200 1984 750 763
38. D.E. Kenady B.W. Brown C.M. McBride Excision of underlying fascia witha primary malignant melanoma: Effect on recurrence and survival rates Surgery 92 1982 615 618
39. C.G. Klopp T.C. Alford J. Bateman Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride: A preliminary report Ann. Surg. 132 1950 811 832
40. C.O. Knutson J.M. Hori J.S. Spratt Jr Melanoma Curr. Probl. Surg. December, 1971 1 55
41. H.S. Koops J. Oldhoff Isolated perfusion of the extremities. Hyperthermicregional perfusion in high-risk stage-I malignant melanomas of the extremities Recent Results Cancer Res. 86 1983 223 228
42. H.S. Koops J. Oldhoff E. van der Ploeg Some aspects of the treatment ofprimary malignant melanoma of the extemities by isolated regional perfusion Cancer 39 1977 27 33
43. A.W. Kopf M. Mintzis R.S. Bart Diagnostic accuracy in malignant melanoma Arch. Dermatol. 111 1975 1291 1292
44. Y-T.N. Lee Diagnosis, treatment and prognosis of early melanoma: The importance of depth of microinvasion Ann. Surg. 191 1980 87 96
45. J.H. Little N.C. Davis Frozen section diagnosis of suspected malignant melanoma of the skin Cancer 34 1974 1163 1172
46. J.M. Luck Action of P-[Di(2-chloroethyl)]-amino-L-phenylalanine on Harding-Passeymouse melanoma Science 123 1956 948 985
47. H. Martijn J. Oldhoff J.W. Oosterhuis H.S. Koops Indications for electivegroin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion Cancer 52 1983 1526 1534
48. M.J. Mastrangelo S.A. Rosenberg A.R. Baker H.R. Kutz Cutaneous melanoma V.T. DeVita Jr S. Hellman S.A. Rosenberg Cancer. Principles and Practice of Oncology 1982 J. B. Lippincott Co., Philadelphia
49. C.M. McBride E.V. Sugarbaker R.C. Hickey Prophylactic isolation-perfusionas the primary therapy for invasive malignant melanoma of the limbs Ann. Surg. 182 1972 316 324
50. G.W. Milton H.M. Shaw W.H. McCarthy Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients Br. J. Surg. 69 1982 108 111
51. D.L. Morton J.E. Goodnight Jr Clinical trials of immunotherapy. Present status Cancer 42 1978 2224 2233
52. T.P.F. O'Connor H.P. Labandter R.W. Hiles D.C. Bodenham A clinicaltrial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma Br. J. Plast. Surg. 31 1978 317 322
53. G. Olsen Removal of fascia-cause of more frequent metastases of malignant melanomasof the skin to regional lymph nodes Cancer 17 1964 1159 1164
54. G.T. Pack S.L. Perzik I.M. Scharnagel The treatment of malignant melanoma. Report of 862 cases Calif. Med. 66 1947 283 287
55. S.L. Perzik R.K. Baum Individualization in the management of melanoma: Areview of 164 consecutive cases Am. Surg. 35 1969 177 180
56. H.C. Polk Jr B.S. Linn Selective regional lymphadenectomy for melanoma: Amathematical aid to clinical judgment Ann. Surg. 174 1971 402 413
57. H.C. Polk Jr J.D. Cohn J.G. Clarkson An appraisal of elective regionallymphadenectomy for melanoma Curr. Top. Surg. Res. 1 1969 121 132
58. V.B. Rege L.A. Leone C.H. Soderberg Hyperthermic adjuvant perfusionchemotherapy for stage I malignant melanoma of the extremity with literature review Cancer 52 1983 2033 2039
59. D.S. Reintgen D.E. Pauli H.F. Seigler Sex related survival differences ininstances of melanoma Surg. Gynecol. Obstet. 159 1984 367 372
60. D.B. Rochlin C.R. Smart Treatment of malignant melanoma by regional perfusion Cancer 18 1965 1544 1550
61. D.F. Roses A.B. Ackerman M.N. Harris Assessment of biopsy techniquesand histopathologic interpretations of primary cutaneous malignant melanoma Ann. Surg. 189 1979 294 297
62. H.F. Seigler B.F. Fetter Surgical progress. Current management of melanoma Ann. Surg. 186 1977 1 12
63. H.F. Seigler E. Cox F. Mutzner Specific active immunotherapy for melanoma Ann. Surg. 190 1979 366 372
64. R. Shafir J. Hiss H. Tsur J.J. Bubis Pitfalls in frozen section diagnosis ofmalignant melanoma Cancer 51 1983 1168 1170
65. H.M. Shaw V.J. McGovern G.W. Milton Malignant melanoma: Influence ofsite of lesion and age of patient in the female superiority in survival Cancer 46 1980 2731 2735
66. W.W. Shingleton Perfusion chemotherapy for recurrent melanoma of extremity: Aprogress report Ann. Surg. 169 1969 969 973
67. F.H. Sim W.F. Taylor J.C. Ivins A prospective randomized study of theefficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results Cancer 41 1978 948 956
68. J.S. Stehlin Jr Hyperthermic perfusion for melanoma of the extremities: Experiencewith 165 patients, 1967 to 1979 Ann. N. Y. Acad. Sci. 335 1980 352 355
69. J.S. Stehlin Jr R.I. Clark Jr E.C. White Regional chemotherapy forcancer: Experiences with 116 perfusions Ann. Surg. 151 1960 605 619
70. J.S. Stehlin Jr B.C. Giovanella P.D. de Ipolyi Results of hyperthermicperfusion for melanoma of the extremities Surg. Gynecol. Obstet. 140 1975 339 348
71. M.M. Urist W.A. Maddox J.E. Kennedy C.M. Balch Patient risk factorsand surgical morbidity after regional lymphadenectomy in 204 melanoma patients Cancer 51 1983 2152 2156
72. O.B. Urteaga G.T. Pack On the antiquity of melanoma Cancer 19 1966 607 610
73. U. Veronesi J. Adamus D.C. Bandiera Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities Cancer 49 1982 2420 2430
74. E. Veronesi J. Adamus D.C. Bandiera Inefficacy of immediate node dissectionin stage I melanoma of the limbs N. Engl. J. Med. 297 1977 627 630
75. U. Veronesi N. Cascinelli Surgical treatment of malignant melanoma of the skin World J. Surg. 3 1979 279 288
76. D.E. Wagner A retrospective study of regional perfusion for melanoma Arch. Surg. 111 1976 410 413
77. H.J. Wanebo J.G. Fortner j. Woodruff Selection of the optimum surgicaltreatment of stage I melanoma by depth of microinvasion: Use of combined microstage technique (Clark-Breslow) Ann. Surg. 182 1975 302 312
78. H.J. Wanebo J. Woodruff J.G. Fortner Malignant melanoma of the extremities:A clinicopathologic study using levels of invasion (microstage) Cancer 35 1975 666 676
79. White, M. J., and Polk, H. C., Jr.: Adjunctive measures in surgical treatment. In: McKenna, R. J., and Murphy, C'. P. (eds.): Fundamentals of Surgical Oncology. New York, Macmillan Publishing Co., in press.